Increased muscle ubiquitin mrna levels in gastric cancer patients

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Bossola, Maurizio ^a   Muscaritoli, Maurizio ^b   Costelli, Paola ^c   Bellantone, Rocco ^a   Pacelli, Fabio ^a   Busquets, Silvia ^d   Argilès, Josef ^d   Lopez Soriano, Francisco J ^d   Civello, Ignazio M ^a   Baccino, Francesco M ^c,e   Rossi Fanelli, Filippo ^b   Doglietto, Giovan Battista ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Unversità di Torino   (Italy)

^d UNIVERSITY OF BARCELONA   (Spain)

^e CNR   (Italy)

Author keywords

Cachexia; Protein breakdown; Proteolytic pathways

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MUSCLE METABOLISM; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECTUS ABDOMINIS MUSCLE; STOMACH CANCER;

EID: 0035034261     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.5.r1518     Document Type: Article

References (41)

1. Aderka D, Fisher S, Levo Y, Holtmann H, Hahn T, and Wallach D. Cachectin/tumour-necrosis-factor production by cancer patients. Lancet 2: 1190, 1985.
2. Argilés JM, Costelli P, Carbó N, Pallarés-Trujillo J, and Lopez-Soriano FJ. Tumour growth and nitrogen metabolism in the host. Int J Oncol 14: 479-486, 1999.
3. Balkwill F, Osborne R, Burke F, Naylor S, Talbot D, Durbin H, Tavernier J, and Fiers W. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 2: 1229-1232, 1987.
4. Baracos VE, DeVivo C, Hoyle DH, and Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol Endocrinol Metab 268: E996-E1006, 1995.
5. Biolo G, Bosutti A, Iscra F, Toigo G, Gullo A, and Guarnieri G. Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients. Metabolism 49: 689-691, 2000.
6. Bond U and Schlesinger MJ. Ubiquitin is a heat-shock protein in chicken-embryo fibroblasts. Mol Cell Biol 5: 949-956, 1985.
7. Carafoli E and Molinari M. Calpain: a protease in search of a function? Biochem Biophys Res Commu 247: 193-203, 1998.
8. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162: 156-159, 1987.
9. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 79: 13-21, 1994.
10. Costelli P, Carbó N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argiles JM, and Baccino FM. Tumor necrosis factor-alpha mediates charges in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993.
11. Costelli P, Garcia-Martinez C, Llovera M, Carbó N, Lopez-Soriano FJ, Agell N, Tessitore L, Baccino FM, and Argiles JM. Muscle protein wasting in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest 95: 2367-2372, 1995.
12. DeWys W. Management of cancer cachexia. Semin Oncol 12: 452-460, 1985.
13. Furuno K and Godberg AL. The activation of protein degradation in muscle by calcium or muscle injury does not involve a lysosomal mechanism. Biochem J 237: 859-864, 1986.
14. Gagnon B and Bruera E. A review of the drug treatment of cachexia associated with cancer. Drugs 55: 675-688, 1998.
15. Gronostajski RM, Goldberg AL, and Pardee A. The role of increased proteolysis in the atrophy and arrest of cell division in fibroblast following serum deprivation. J Cell Biol 121: 189-198, 1984.
16. Hilenski LL, Terracio L, Haas AL, and Borg TK. Immuno-localization of ubiquitin conjugates at Z-bands and intercalated discs of rat cardiomyocytes in vitro and in vivo. J Histochem Cytochem 40: 1037-1042, 1992.
17. Kettlehut IC, Wing SS, and Godberg AL. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev 4: 751-772, 1988.
18. Kien CL and Camitta BM. Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. Cancer Res 43: 5586-5592, 1983.
19. Kien CL and Camitta BM. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. J Parent Enter Nutr 11: 129-134, 1987.
20. Lawson DH, Richmond A, Nixon DW, and Rudman D. Metabolic approaches to cancer cachexia. Annu Rev Nutr 2: 277-301, 1982.
21. Llovera M, Carbo N, Garcia-Martinez C, Costelli P, Tessitore L, Baccino FM, Agell N, Bagby GJ, Lopez-Soriano FJ, and Argiles JM. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun 221: 653-655, 1996.
22. Llovera M, Carbo N, Lopez-Soriano J, Garcia-Martinez C, Busquets S, Alvarez B, Agell N, Costelli P, Lopez-Soriano FJ, Celada A, and Argiles JM. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 133: 83-87, 1998.
23. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Authier FJ, Gherardi RK, and Argiles JM. Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. Int J Mol Med 2: 69-73, 1998.
24. Llovera M, Garcia-Martinez C, Agell N, Marzabal M, Lopez-Soriano FJ, and Argiles JM. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett 338: 311-318, 1994.
25. Llovera M, Lopez-Soriano FJ, and Argiles JM. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst 85: 1334-1339, 1993.
26. MacLennon PA, McArdle A, and Edwards RHT. Effect of calcium on protein turnover in incubated muscles from mdx mice. Am J Physiol Endocrinol Metab 260: E594-E598, 1991.
27. 2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci USA 93: 2714-2718, 1996.
28. Melville S, McNurlan MA, Calder AG, and Garlick PJ. Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res 50: 1125-1131, 1990.
29. Muscaritoli M, Meguid MM, Beverly JL, Yang ZJ, Cangiano C, and Rossi-Fanelli F. Mechanism of early tumor anorexia. J Surg Res 60: 389-397, 1996.
30. Pallares-Trujillo J, Agell N, Garcia-Martinez C, Lopez-Soriano FJ, and Argiles JM. The ubiquitin system: a role in disease? Med Res Rev 17: 139-161, 1998.
31. Saarinen UM, Koskelo EK, Teppo AM, and Siimes MA. Tumor necrosis factor in children with malignancies. Cancer Res 50: 592-595, 1990.
32. Shibata M, Takekawa M, and Amano S. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer. Surg Today 28: 884-888, 1998.
33. Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A, Bechet D, Ferrara M, Estrela JM, and Attaix D. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 54: 5568-5573, 1994.
34. Tessitore L, Costelli P, and Baccino FM. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J 299: 71-78, 1994.
35. Tessitore L, Costelli P, and Baccino FM. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer 67: 15-23, 1993.
36. Tessitore L, Costelli P, Bonetti G, and Baccino FM. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys 306: 52-58, 1993.
37. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, and Hasselgren PO. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 99: 163-168, 1997.
38. Union Internationale Cotre le Cancer. TNM Classification of Malignant Tumors (4th ed.). Geneva: UICC, 1987.
39. 2+-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97: 1610-1617, 1997.
40. Williams A, Sun X, Fischer JE, and Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 126: 744-749, 1999.
41. Wing S and Goldberg AL. Glucocorticoids activate the ATP-ubiquitm-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol Endocrinol Metab 264: E668-E676, 1993.